COVID Omicron News: FDA expands eligibility for remdesivir to anyone with mild to moderate symptoms

NEW YORK (WABC) — The Food and Drug Administration has extended the use of the antiviral remdesivir for treatment of mild to moderate COVID-19. The medication had received emergency use authorization in May 2020. Back then it was only for use in people hospitalized with severe COVID-19. In October of that year, it was approved … Read more

Omicron vs. Delta: See Which Vaccines Worked Best, Booster Effect & More in Study

What to Know The CDC looked at COVID infections for the unvaccinated vs. fully vaccinated across the delta and omicron variant waves in 25 jurisdictions, including New York, New York City and New Jersey Overall, it found vaccine effectiveness plunged during omicron vs. delta; fully vaccinated people with Pfizer had the highest weekly infection rate … Read more

x